Tokushima-based SetsuroTech offers gene editing contract research services and genome-edited animal models.
Founded in 2017 in Tokushima-shi, Japan, SetsuroTech sells gene editing contract services and genome-edited models such as mice, rats and cells to academic institutions and biotechnology companies, mainly in Japan and Asia. Revenue comes from project-based service contracts. In January 2026 it raised JPY 320 million in a Series A round from EXPONENTIAL ZAISAN PARTNERS, Inspire Corporation, Osaka Small and Medium Business Investment & Consultation, Iyogin Capital and HOXIN, with returning investor SBI Investment also participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in